Skip to search formSkip to main contentSkip to account menu

CSA-90

Known as: ceragenin CSA-90 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Background Therapeutic efficiency of ceragenins against cancers may be limited by lack of their hemocompatibility when high… 
2020
2020
Infection of orthopedic implants is a growing clinical challenge to manage due to the proliferation of drug-resistant bacterial… 
Review
2020
Review
2020
Osteomyelitis and infections associated with orthopedic implants represent a significant burden of disease worldwide. Ceragenins… 
2018
2018
Ceragenins were designed as non-peptide mimics of endogenous antimicrobial peptides, and they display broad-spectrum… 
Review
2018
Review
2018
Background Infection of open fractures remains a significant cause of morbidity and mortality to patients worldwide. Early… 
2017
2017
Spore-forming bacteria are a class of microorganisms that possess the ability to survive in extreme environmental conditions… 
2017
2017
Fungal infections caused by Candida spp. represent an emerging problem during treatment of immunocompromised patients and those… 
2015
2015
BACKGROUND Treatment of infected open fractures remains a major clinical challenge. In this study, we investigated the novel… 
2014
2014
Ceragenin CSA-13, a cationic steroid, is here reported to show a concentration-dependent bactericidal/bacteriolytic activity… 
Highly Cited
2013
Highly Cited
2013
OBJECTIVES We aim to develop antibacterial peptide mimics resistant to protease degradation, with broad-spectrum activity at…